HMGB1, RAGE

PHA Biologicals

32375153 2020. HMGB1: A Possible Crucial Therapeutic Target for COVID-19?
23607598 2013. (x)Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome
32380958 2020. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
32531537 2020. RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?
32600307 2020. The alpha7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation.
32629817 2020. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.
32723229 2020. Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection?
33236418 2020. HMGB1: A pleiotropic activity.
32760352 2020. COVID-19 and Diabetes: The Importance of Controlling RAGE.